Global Companion Animal Parasiticides Market Size By Type (Endoparasiticides, Ectoparasiticides), By Application (Dogs/Cats, Equine), By Region, And Segment Forecasts, 2023 to 2032

The Global Companion Animal Parasiticides Market was valued at USD 6.3 billion in 2023 and is projected to reach USD 10.4 billion by 2031, growing at a CAGR of 6.7% from 2023 to 2031. The market is witnessing robust growth due to the increasing pet adoption rates, rising awareness regarding pet health and hygiene, and the growing prevalence of zoonotic diseases. Companion animal parasiticides—comprising ectoparasiticides, endoparasiticides, and endectocides—play a crucial role in safeguarding pets against fleas, ticks, mites, and internal parasites.

Drivers:

1. Surge in Pet Ownership and Expenditure on Pet Health:

There is a growing human-animal bond globally, especially in urban households, leading to increased spending on preventive healthcare for pets. Owners are investing more in high-quality parasitic treatments to ensure longevity and comfort for their pets.

2. Rise in Zoonotic Disease Awareness:

With diseases like Lyme disease and leishmaniasis gaining attention, the importance of regular parasitic treatment is emphasized more by veterinarians and regulatory bodies.

3. Advancements in Veterinary Parasiticides:

Innovations in long-lasting formulations, palatable oral chewables, and combination therapies are boosting market adoption, especially for products offering dual or broad-spectrum protection.

Restraints:

1. Stringent Regulatory Approvals:

Parasiticide products undergo rigorous regulatory scrutiny, which can delay product launches and inflate R&D costs.

2. Risk of Antiparasitic Resistance:

Improper use or overuse of parasiticides can lead to drug resistance, reducing their long-term efficacy and posing a threat to market sustainability.

Opportunity:

1. Growth in E-commerce and Subscription-based Pet Healthcare:

Digital platforms and recurring delivery models are making parasiticide products more accessible to pet owners, enhancing market penetration.

2. Expanding Companion Animal Population in Emerging Markets:

Countries in Asia-Pacific and Latin America are seeing a rising pet population and increased veterinary service access, opening new avenues for parasiticide manufacturers.

Market by System Type Insights:

Ectoparasiticides led the market in 2023, attributed to their critical role in controlling fleas and ticks, which are the most common external parasites in pets. Topical and oral treatments in this segment have gained popularity due to ease of application and extended protection. Meanwhile, the Endectocides segment is projected to grow at the highest CAGR owing to its dual action on internal and external parasites.

Market by End-use Insights:

Veterinary Clinics and Hospitals held the largest revenue share in 2023, driven by increased pet visits and professional guidance for parasite prevention. Home care/self-administration by pet owners is growing rapidly, propelled by easy-to-use over-the-counter formulations and the influence of online pet health platforms.

Market by Regional Insights:

North America dominated the global companion animal parasiticides market in 2023, thanks to high pet ownership, advanced veterinary healthcare infrastructure, and proactive pet care culture. Asia-Pacific is expected to witness the fastest growth during the forecast period, driven by rising disposable incomes, urbanization, and growing awareness of pet wellness in countries such as China, India, and South Korea.

Competitive Scenario:

Leading players in the global companion animal parasiticides market include Boehringer Ingelheim, Elanco Animal Health, Zoetis Inc., Bayer AG (now part of Elanco), Virbac, Ceva Santé Animale, and Vetoquinol SA. These companies are investing heavily in R&D, launching combination treatments, and expanding their digital reach to capture growing demand.

Scope of Work – Global Companion Animal Parasiticides Market

Key Market Developments:

2023: Zoetis launched a next-generation endectocide combining flea, tick, and intestinal worm protection in a single monthly chew for dogs.

2024: Elanco completed the acquisition of Bayer Animal Health’s parasiticide product line, enhancing its market portfolio.

2025: Virbac announced its entry into the South American companion animal parasiticide market with localized formulations tailored for tropical parasite challenges.

FAQs:

1) What is the current market size of the Global Companion Animal Parasiticides Market?

The market was valued at USD 6.3 billion in 2023.

2) What is the major growth driver of the Global Companion Animal Parasiticides Market?

The key growth driver is the increasing awareness and expenditure on preventive healthcare for pets, particularly for parasite control.

3) Which is the largest region during the forecast period in the Global Companion Animal Parasiticides Market?

North America holds the largest market share, driven by a mature pet care industry and strong veterinary infrastructure.

4) Which segment accounted for the largest market share in Global Companion Animal Parasiticides Market?

The Ectoparasiticides segment led the market in 2023 due to high demand for flea and tick control solutions.

5) Who are the key market players in the Global Companion Animal Parasiticides Market?

Key players include Zoetis Inc., Elanco Animal Health, Boehringer Ingelheim, Virbac, Ceva Santé Animale, and Vetoquinol SA.